The molecular mechanisms of congenital hypofibrinogenaemia (Q35805441)

10 August 2017

1 reference

title

The molecular mechanisms of congenital hypofibrinogenaemia (English)

1 reference

10 August 2017

0 references

1

Maghzal GJ

1 reference

10 August 2017

2

Brennan SO

1 reference

10 August 2017

4

George PM

1 reference

10 August 2017

Homer VM

3

1 reference

10 August 2017

1 June 2004

1 reference

Cellular and Molecular Life Sciences

10 August 2017

1 reference

10 August 2017

61

1 reference

10 August 2017

12

1 reference

10 August 2017

1427-1438

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-004-3458-8

10 August 2017

0 references

cites work

Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model

1 reference

12 December 2020

Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study

1 reference

12 December 2020

Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans

1 reference

12 December 2020

First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial

1 reference

12 December 2020

Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.

1 reference

12 December 2020

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

1 reference

12 December 2020

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

1 reference

12 December 2020

3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System i

1 reference

12 December 2020

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

1 reference

12 December 2020

Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent i

1 reference

12 December 2020

Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents

1 reference

12 December 2020

Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions

1 reference

12 December 2020

Endothelial cell recovery between comparator polymer-based drug-eluting stents

1 reference

12 December 2020

Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial

1 reference

12 December 2020

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

1 reference

12 December 2020

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial.

1 reference

12 December 2020

Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).

1 reference

12 December 2020

Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents

1 reference

12 December 2020

The next-generation Endeavor Resolute stent: 4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial.

1 reference

12 December 2020

Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents

1 reference

12 December 2020

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

1 reference

12 December 2020

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

12 December 2020

A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial

1 reference

12 December 2020

Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss

1 reference

12 December 2020

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial

1 reference

12 December 2020

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

12 December 2020

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

12 December 2020

Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).

1 reference

12 December 2020

Everolimus or paclitaxel stents in real life: go COMPARE.

1 reference

12 December 2020

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

1 reference

12 December 2020

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

1 reference

12 December 2020

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

12 December 2020

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

12 December 2020

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial

1 reference

12 December 2020

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

1 reference

12 December 2020

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

1 reference

12 December 2020

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

12 December 2020

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

1 reference

12 December 2020

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

12 December 2020

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

1 reference

12 December 2020

Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation.

1 reference

12 December 2020

Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial

1 reference

12 December 2020

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

1 reference

12 December 2020

Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2)

1 reference

12 December 2020

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

1 reference

12 December 2020

10.1007/S00018-004-3458-8

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15197468